Cognita Imaging received a $1.29 million research contract from the Food and Drug Administration to test a new method of evaluating artificial intelligence-generated radiology reports.

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

FDA approvals, clinical trial design, psychedelic drug policy, compounding pharmacy regulation, and drug scheduling.

AI research advances and the benchmarks used to measure progress.